3rd International Conference on Influenza and Zoonotic Diseases August 21-22 2017 Birmingham,UK

Baik Lin Seong, PhD, Professor of Biotechnology, and director of Vaccine Translational Research Center(VTRC) at Yonsei University, established scientific experience from basic molecular biology to pre-clinical development of vaccines and therapeutic proteins. He received B.S. from Seoul National University (1977) and PhD from MIT (1988). Dr. Seong served as director of the Institute of Biological Sciences at Hanhyo Institute (1993-1998), and represented the Korean Government for Biological Weapons Convention (BWC) in United Nations (2000-2008).

His research of interest include designing universal flu vaccine, virus-like particles (VLPs) vaccines for viral and microbial infections.

A/Professor Farhid Hemmatzadeh is a virologist at the School of Animal & Veterinary Sciences The University of Adelaide, Australia. Farhid has over 20 years’ experience in research and teaching at the field of animal viral diseases including paramyxoviruses, herpesviruses, pestiviruses, retroviruses, parvoviruses and influenza viruses. In last 12 years since pandemic of highly pathogenic influenza viruses Farhid has been involved in research, development and assessment of diagnostic test for avian influenza in South East Asia especially in Indonesia. A/Prof Hemmatzadeh has supervised numbers of PhD project and led international collaboration in the field of avian Influenza Viruses.

His Research of Interest is animal viral diseases including paramyxoviruses, herpesviruses, pestiviruses, retroviruses, parvoviruses and influenza viruses

Ludmila Viksna is one of the most experienced experts in Infectology and Hepatology in Latvia. She is the professor of Medical Sciences, the member of Senate and the head of the Department of Infectology and Dermatology of Riga Stradins University, the member of Medicinal Council and the Chief Specialist in Infectology of Riga East Clinical University Hospital. L.Viksna is the corresponding member of the Latvian Academy of Sciences, the member of Coordination committee of the Ministry of Health of LR on control and elimination of HIV, tuberculosis and sexually transmitted infections, and the president of the Association of Infectologists and Hepatologists of Latvia. Professor L.Viksna is the holder of 15 national patents, the author of 5 books and the member of editorial boards of several local and international scientific journals.

Her Research of Interest is Hepatology Infectious diseases Family medicine Deontological (medicine) ethics

Yizhi Jane Tao, Ph.D., is a Chinese biochemist, structural biologist, and Professor of Biochemistry and Cell Biology at Rice University in Houston, Texas. Professor Tao led a team of researchers to be the first to map the structure of the influenza A virus nucleoprotein to an atomic level, a feat which circulated widely in the popular She was named among the top ten most influential Chinese of 2006 by a consortium of China's leading media outlets including Phoenix Satellite Television, China News Service, Asia Newsweek, and World Journal.

Her Research of interest in the catalytic mechanisms of viral RNA polymerases and in how RNA viruses exert regulation over RNA synthesis through polymerase interactions with viral and cellular factors.

Dr. Edmond Puca has received his PhD in University Hospital Center Mother Teresa during the period of 2010-2014. Currently, he is working as infectologue in University Hospital Center “Mother Teresa”.He is a member of Albanian Society of infectology.He is serving as an editorial member as well as reviewer for several reputed journals.

His research includes sepsis, HFRS and leptospirosis

Mohammed Q. Al-Natour is a Professor of Avian Diseases & Public Health,Bureau member of the WVPA, since 2011, President of the Jordanian Veterinary Poultry Association-WVPA, since 2011,FAO National Consultant; Expert for Avian Influenza, 2007,OIE Scientific Collaborator for Avian Influenza, 2005,OIE Scientific Collaborator for Avian Influenza, 2005

His Research of Interest is Avian Influenza & Avian-Human Pathogens of Public Health Importance Active and Passive Disease Surveillance; Prevalence & Risk factors Food Security & Safety: Antimicrobial Resistance to campylobacter spp Food Security & Safety: Antimicrobial Resistance to campylobacter spp

Dr. Peuschel has studied medicine and molecular biology at the University of Zurich, as well as psychiatry and psychotherapy at the University of Lausanne. She has completed her MD from the University of Zurich, has worked in research in molecular biology at the University of Zurich and has obtained federal diplomas in general medicine as well as in psychiatry and psychotherapy. She is currently head of department at the Medicine and Health Clinic in Switzerland. She has published 7 papers indexed in PubMed, she has been presenting her work at various conferences, and has been invited to conferences in Europe, the US, China, Japan, Thailand, India and the United Arab Emirates.

Her Research of interest is Antibiotic therapy corroborated by selected immunomodulating betablockers

Dr ZHU is an Assistant Professor at The University of Hong Kong (HKU) and Adjunct Professor at Shantou University (STU), China. She currently serves as Associate Director of the Joint Institute of Virology (STU/HKU) and the State Key Laboratory of Emerging Infectious Diseases (HKU-Shenzhen Branch). She is also Co-director of the Joint Laboratory for International Cooperation in Virology and Emerging Infectious Diseases, Ministry of Education, China. Her research focused on influenza and other emerging infectious diseases. Over the past years, she has been at the forefront of assessing risks of emerging viruses and identifying threats to human health through emerging viral diseases, bringing about fundamental understanding of how viruses develop at the human and animal interface.

Discovery of novel disease agents and unknown virome in animals and humans Ecology and evolution of emerging RNA viruses Molecular basis of the pathogenicity and transmissibility of influenza viruses; • Oncolytic viruses and virotherapy.

Received a Ph.D. in Biochemistry in 1973, a D.Sci. in 1983. Held progressively responsible positions at Russian Academy of Science. In USA: Senior Scientist at NCI, NIH (1991-95); professor (1995-2010, visiting professor (2010- ) at Mount Sinai School of Medicine. In 2005, founded XENOTOX, Inc., an innovation science consulting company. Has forty years of experience in studies on drug metabolising CYPs. Established and developed Xenobiotical Virology, an interdisciplinary biomedical discipline dealing with mechanisms of potent xenobiotics’ effect on DRE-containing genes of human viruses, transcription factors and cytokines linked to inflammation and malignancy pathways. Author of 4 monographs and 250+ peer-reviewed publications.

Yulia A. Desheva is a Senior Scientist in Virology Dept Her work experience is Oct. 1995 until now – scientist, the Institute of Experimental Medicine, RAMS. Professor, Saint Petersburg State University Responsibilities areWorking-out of live-attenuated vaccine for potential pandemic. The preclinical and clinical studies of reactogenicity and immunogeniciy of live reassortant influenza vaccines (LAIV). Working-out of the optimal scheme of influenza vaccination in elderly with chronically disorders. Clinical trials of LAIV in children 3-6 years old (reactogenicity, genetic stability, immunogenicity, efficasy). Serology, influenza virus isolation, genetic reassortment, RT-PCR, sequencing, molecular analysis, cell culture technique. Evaluation of influenza vaccines in animal models (mice, ferrets). Evaluation of antibodies to influenza virus neuraminidase. Associated viral-bacterial vaccines. Sept.1992-Oct.1995 - research scientist, The Institute for Influenza RAMS Sept. 1990-Sept. 1992 – postgraduate student in infectious diseases clinic. The Institute for Influenza RAMS Sept. 1983 - Sept. 1990 - Medical doctor, Public health system, therapy

Her Research of Interest is Evaluation of influenza vaccines in animal models (mice, ferrets). Evaluation of antibodies to influenza virus neuraminidase. Associated viral-bacterial vaccines.

Giulio Tarro graduated from Medicine School, Naples University (1962). Research Associate, Division of Virology and Cancer Research, Children’s Hospital (1965-1968), Assistant Professor of Research Pediatrics, College Medicine (1968-1969), Cincinnati University, Ohio. Oncological Virology Professor, Naples University (1972-1985). Chief Division Virology (1973-2003), Head Department Diagnostic Laboratories, (2003-2006). D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus, 2006 -. Since 2007 Chairman Committee of Biotechnologies and VirusSphere, World Academy Biomedical Technologies, UNESCO, Adjunct Professor Department Biology, Temple University, College of Science and Technology, Philadelphia, recipient of the Sbarro Health Research Organization lifetime achievement award (2010). President Foundation de Beaumont Bonelli for Cancer Research.

His research interest are Viral Oncology, Tumor Liberated Protein (TLP), Emerging Viral Agents at Risk in Global Health Approaches to Early Diagnosis and Prompt Therapy.

Giulio Tarro graduated from Medicine School, Naples University (1962). Research Associate, Division of Virology and Cancer Research, Children’s Hospital (1965-1968), Assistant Professor of Research Pediatrics, College Medicine (1968-1969), Cincinnati University, Ohio. Oncological Virology Professor, Naples University (1972-1985). Chief Division Virology (1973-2003), Head Department Diagnostic Laboratories, (2003-2006). D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus, 2006 -. Since 2007 Chairman Committee of Biotechnologies and VirusSphere, World Academy Biomedical Technologies, UNESCO, Adjunct Professor Department Biology, Temple University, College of Science and Technology, Philadelphia, recipient of the Sbarro Health Research Organization lifetime achievement award (2010). President Foundation de Beaumont Bonelli for Cancer Research.

His research interest are Viral Oncology, Tumor Liberated Protein (TLP), Emerging Viral Agents at Risk in Global Health Approaches to Early Diagnosis and Prompt Therapy.